TY - JOUR
T1 - Effect of a foot-drop stimulator and ankle-foot orthosis on walking performance after stroke
T2 - A multicenter randomized controlled trial
AU - Everaert, Dirk G.
AU - Stein, Richard B.
AU - Abrams, Gary M.
AU - Dromerick, Alexander W.
AU - Francisco, Gerard E.
AU - Hafner, Brian J.
AU - Huskey, Thy N.
AU - Munin, Michael C.
AU - Nolan, Karen J.
AU - Kufta, Conrad V.
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This trial was sponsored by Innovative Neurotronics Inc, Austin, Texas, which manufactures and sells the WalkAide foot-drop stimulator used in this trial. Innovative Neurotronics is a subsidiary of Hanger Orthopedic Group. Most ankle–foot orthoses used in this trial were fabricated by orthotists associated with the Hanger Orthopedic Group.
PY - 2013/9
Y1 - 2013/9
N2 - Background. Studies have demonstrated the efficacy of functional electrical stimulation in the management of foot drop after stroke. Objective. To compare changes in walking performance with the WalkAide (WA) foot-drop stimulator and a conventional ankle-foot orthosis (AFO). Methods. Individuals with stroke within the previous 12 months and residual foot drop were enrolled in a multicenter, randomized controlled, crossover trial. Subjects were assigned to 1 of 3 parallel arms for 12 weeks (6 weeks/device): arm 1 (WA-AFO), n = 38; arm 2 (AFO-WA), n = 31; arm 3 (AFO-AFO), n = 24. Primary outcomes were walking speed and Physiological Cost Index for the Figure-of-8 walking test. Secondary measures included 10-m walking speed and perceived safety during this test, general mobility, and device preference for arms 1 and 2 for continued use. Walking tests were performed with (On) and without a device (Off) at 0, 3, 6, 9, and 12 weeks. Results. Both WA and AFO had significant orthotic (On-Off difference), therapeutic (change over time when Off), and combined (change over time On vs baseline Off) effects on walking speed. An AFO also had a significant orthotic effect on Physiological Cost Index. The WA had a higher, but not significantly different therapeutic effect on speed than an AFO, whereas an AFO had a greater orthotic effect than the WA (significant at 12 weeks). Combined effects on speed after 6 weeks did not differ between devices. Users felt as safe with the WA as with an AFO, but significantly more users preferred the WA. Conclusions. Both devices produce equivalent functional gains.
AB - Background. Studies have demonstrated the efficacy of functional electrical stimulation in the management of foot drop after stroke. Objective. To compare changes in walking performance with the WalkAide (WA) foot-drop stimulator and a conventional ankle-foot orthosis (AFO). Methods. Individuals with stroke within the previous 12 months and residual foot drop were enrolled in a multicenter, randomized controlled, crossover trial. Subjects were assigned to 1 of 3 parallel arms for 12 weeks (6 weeks/device): arm 1 (WA-AFO), n = 38; arm 2 (AFO-WA), n = 31; arm 3 (AFO-AFO), n = 24. Primary outcomes were walking speed and Physiological Cost Index for the Figure-of-8 walking test. Secondary measures included 10-m walking speed and perceived safety during this test, general mobility, and device preference for arms 1 and 2 for continued use. Walking tests were performed with (On) and without a device (Off) at 0, 3, 6, 9, and 12 weeks. Results. Both WA and AFO had significant orthotic (On-Off difference), therapeutic (change over time when Off), and combined (change over time On vs baseline Off) effects on walking speed. An AFO also had a significant orthotic effect on Physiological Cost Index. The WA had a higher, but not significantly different therapeutic effect on speed than an AFO, whereas an AFO had a greater orthotic effect than the WA (significant at 12 weeks). Combined effects on speed after 6 weeks did not differ between devices. Users felt as safe with the WA as with an AFO, but significantly more users preferred the WA. Conclusions. Both devices produce equivalent functional gains.
KW - drop foot
KW - functional electrical stimulation
KW - mobility
KW - physiological cost
KW - stroke rehabilitation
KW - walking speed
UR - http://www.scopus.com/inward/record.url?scp=84881002506&partnerID=8YFLogxK
U2 - 10.1177/1545968313481278
DO - 10.1177/1545968313481278
M3 - Article
C2 - 23558080
AN - SCOPUS:84881002506
SN - 1545-9683
VL - 27
SP - 579
EP - 591
JO - Neurorehabilitation and neural repair
JF - Neurorehabilitation and neural repair
IS - 7
ER -